Role of Proenkephalin in Assessing Recovery from AKI and AKI-D
Discover new diagnostic insights presented by Dr. Christian Nusshag at the 29th AKI & CRRT in San Diego. During his presentation on…
Practice-Oriented Management of Acute Dialysis in Cardiac Surgery Patients: Strategies and Challenges in Clinical Practice
Join Professor Bernardi from Vienna for an informative webinar on the…
Next to our Nexus IB10 automated and portable immunoassay system we also provide customized MTP assays and testing services to fulfill the specific requirements of our customers.
Bioactive Adrenomedullin (bio-ADM), is a dynamic biomarker for the real time assessment of endothelial function. Loss of endothelial function is causing the formation of edema, shock and subsequent…
SphingoTec has established an extended intellectual property portfolio covering markers for acute care conditions such as sepsis, acute heart failure and acute kidney injury.
SphingoTec partners with pharmaceutical companies to advance the development of targeted therapies in acute and critical care. Our biomarkers are designed to identify and monitor key disease…
SphingoTec is committed to transforming critical care diagnostics through strategic collaborations, with a strong focus on out-licensing and partnerships with diagnostics and pharmaceutical…
At SphingoTec, we enable cutting-edge research by offering a broad spectrum of high-quality assay solutions. Our approach is shaped by two distinct pathways to support research and diagnostic…
